Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct;39(5):414-7.
doi: 10.1111/1753-6405.12443.

Cancers prevented in Australia in 2010 through the consumption of aspirin

Louise F Wilson  1 , Adele C Green  1   2   3 , Bradley J Kendall  1   4 , Susan J Jordan  1   3 , Christina M Nagle  1   3 , Christopher J Bain  1   5 , Rachel E Neale  1   3 , David C Whiteman  1   3
Affiliations

Cancers prevented in Australia in 2010 through the consumption of aspirin

Louise F Wilson et al. Aust N Z J Public Health. 2015 Oct.

Abstract

Objectives: To estimate the proportion and number of cancers in Australia in 2010 that may have been prevented from occurring due to daily use of aspirin in the population.

Methods: We calculated the Prevented Fraction (PF) of colorectal and oesophageal cancers using standard formulae. The PF is the proportion of the hypothetical total load of cancer in the population that was prevented by exposure to aspirin. The formula incorporates estimates of the prevalence of aspirin use in Australian adult populations, the relative risks associated with aspirin use and cancer incidence.

Results: An estimated 335 colorectal cancers, 22 oesophageal adenocarcinomas and 29 oesophageal squamous cell carcinomas (SCC) were potentially prevented due to daily aspirin use. These figures equate to 2.2%, 3.1% and 5.4% of all colorectal cancers, oesophageal adenocarcinomas and oesophageal SCCs, respectively, that would otherwise have occurred but were potentially avoided due to the daily use of aspirin pertaining in the Australian population.

Conclusions: At current levels of consumption, a small but measurable reduction in cancer incidence can be attributed to daily aspirin use.

Implications: Assuming the benefits outweigh the harms of known gastrointestinal toxicity and other hazards, aspirin use may be considered for some people to prevent the development of particular gastrointestinal cancers.

Keywords: aspirin; cancer; prevented fraction; protective factor.

PubMed Disclaimer

References

    1. Algra AM, Rothwell PM. Effects of regular aspirin on long-term cancer incidence and metastasis: A systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol. 2012;13(5):518–27. - PubMed
    1. Ye X, Fu J, Yang Y, Chen S. Dose-risk and duration-risk relationships between aspirin and colorectal cancer: A meta-analysis of published cohort studies. PLoS One. 2013;8(2):e57578. - PMC - PubMed
    1. Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet. 2010;376(9754):1741–50. - PubMed
    1. Thun MJ, Jacobs EJ, Patrono C. The role of aspirin in cancer prevention. Nat Rev Clin Oncol. 2012;9(5):259–67. - PubMed
    1. Bosetti C, Rosato V, Gallus S, Cuzick J, La Vecchia C. Aspirin and cancer risk: A quantitative review to 2011. Ann Oncol. 2012;23(6):1403–15. - PubMed

Publication types

MeSH terms

Supplementary concepts